AU2179688A - Recombinant eukaryotic cells production interleukin-2, process and vectors for their preparation and process for the preparation of interleukin-2 - Google Patents
Recombinant eukaryotic cells production interleukin-2, process and vectors for their preparation and process for the preparation of interleukin-2Info
- Publication number
- AU2179688A AU2179688A AU21796/88A AU2179688A AU2179688A AU 2179688 A AU2179688 A AU 2179688A AU 21796/88 A AU21796/88 A AU 21796/88A AU 2179688 A AU2179688 A AU 2179688A AU 2179688 A AU2179688 A AU 2179688A
- Authority
- AU
- Australia
- Prior art keywords
- preparation
- interleukin
- vectors
- eukaryotic cells
- recombinant eukaryotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000000588 Interleukin-2 Human genes 0.000 title 2
- 108010002350 Interleukin-2 Proteins 0.000 title 2
- 238000000034 method Methods 0.000 title 2
- 210000003527 eukaryotic cell Anatomy 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/55—IL-2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8712166 | 1987-09-01 | ||
FR8712166A FR2619719B1 (en) | 1987-09-01 | 1987-09-01 | PROCESS FOR OBTAINING INTERLEUKIN-2 FROM EUKARYOTIC CELLS, VECTORS NECESSARY FOR ITS IMPLEMENTATION AND HIGHLY PRODUCING CELL LINES |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2179688A true AU2179688A (en) | 1989-03-02 |
AU606453B2 AU606453B2 (en) | 1991-02-07 |
Family
ID=9354552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU21796/88A Ceased AU606453B2 (en) | 1987-09-01 | 1988-09-01 | Recombinant eukaryotic cells production interleukin-2, process and vectors for their preparation and process for the preparation of interleukin-2 |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0307285A1 (en) |
JP (1) | JPH01165373A (en) |
KR (1) | KR890005264A (en) |
AU (1) | AU606453B2 (en) |
DK (1) | DK467188A (en) |
FI (1) | FI884036A (en) |
FR (1) | FR2619719B1 (en) |
IL (1) | IL87622A0 (en) |
NO (1) | NO883883L (en) |
NZ (1) | NZ225983A (en) |
PT (1) | PT88372B (en) |
ZA (1) | ZA886517B (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU603576B2 (en) * | 1986-05-12 | 1990-11-22 | F. Hoffmann-La Roche Ag | Enhanced expression of human interleukin-2 in mammalian cells |
WO1990015142A1 (en) * | 1989-06-09 | 1990-12-13 | Gropep Pty. Ltd. | Growth hormone fusion proteins |
US5679771A (en) * | 1990-02-13 | 1997-10-21 | Gropep Pty. Ltd. | Method for treating intestinal diseases |
US6083725A (en) * | 1996-09-13 | 2000-07-04 | Transkaryotic Therapies, Inc. | Tranfected human cells expressing human α-galactosidase A protein |
US7833742B2 (en) | 2002-04-25 | 2010-11-16 | Shire Human Genetic Therapies, Inc. | Treatment of α-galactosidase A deficiency |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2639232A1 (en) * | 1988-10-21 | 1990-05-25 | Sanofi Sa | DRUGS CONTAINING A GLYCOSYLATED INTERLEUKIN-2 |
US5417970A (en) * | 1988-10-21 | 1995-05-23 | Sanofi | Drugs containing a glycosylated interleukin-2 |
CA2248653C (en) * | 1996-05-01 | 2003-08-12 | Genitope Corporation | Vaccines for treatment of lymphoma and leukemia |
US5776746A (en) | 1996-05-01 | 1998-07-07 | Genitope Corporation | Gene amplification methods |
EP2374876B1 (en) * | 1996-09-13 | 2016-04-13 | Shire Human Genetic Therapies, Inc. | Purification process of alpha-galactosidase A |
JP2001523480A (en) | 1997-11-20 | 2001-11-27 | バイカル インコーポレイテッド | Treatment of cancer with cytokine-expressed polynucleotides and their compositions |
KR20020043448A (en) * | 2000-12-04 | 2002-06-10 | 리송알렉스인근 | Recombinant protein human interleukin-2 and manufacturing method of same |
IL140110A0 (en) * | 2000-12-05 | 2002-02-10 | Applied Research Systems | Improvement of homogeneity and secretion of recombinant proteins in mammalian systems |
KR20220054579A (en) * | 2019-06-26 | 2022-05-03 | 더 존스 홉킨스 유니버시티 | Methods and Materials for Targeted Expansion of Immune Effector Cells |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0172619A1 (en) * | 1984-06-20 | 1986-02-26 | Takeda Chemical Industries, Ltd. | Novel transformant and use thereof |
US4992367A (en) * | 1986-05-12 | 1991-02-12 | Hoffmann-La Roche Inc. | Enhanced expression of human interleukin-2 in mammalian cells |
-
1987
- 1987-09-01 FR FR8712166A patent/FR2619719B1/en not_active Expired - Fee Related
-
1988
- 1988-08-19 DK DK467188A patent/DK467188A/en not_active Application Discontinuation
- 1988-08-30 PT PT88372A patent/PT88372B/en not_active IP Right Cessation
- 1988-08-30 NZ NZ225983A patent/NZ225983A/en unknown
- 1988-08-31 NO NO88883883A patent/NO883883L/en unknown
- 1988-08-31 IL IL87622A patent/IL87622A0/en unknown
- 1988-09-01 ZA ZA886517A patent/ZA886517B/en unknown
- 1988-09-01 AU AU21796/88A patent/AU606453B2/en not_active Ceased
- 1988-09-01 JP JP63219590A patent/JPH01165373A/en active Pending
- 1988-09-01 FI FI884036A patent/FI884036A/en not_active Application Discontinuation
- 1988-09-01 EP EP88402198A patent/EP0307285A1/en not_active Withdrawn
- 1988-09-01 KR KR1019880011309A patent/KR890005264A/en not_active Application Discontinuation
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU603576B2 (en) * | 1986-05-12 | 1990-11-22 | F. Hoffmann-La Roche Ag | Enhanced expression of human interleukin-2 in mammalian cells |
WO1990015142A1 (en) * | 1989-06-09 | 1990-12-13 | Gropep Pty. Ltd. | Growth hormone fusion proteins |
US5330971A (en) * | 1989-06-09 | 1994-07-19 | Gropep Pty. Ltd. | Growth hormone fusion proteins, methods of production, and methods of treatment |
US5679771A (en) * | 1990-02-13 | 1997-10-21 | Gropep Pty. Ltd. | Method for treating intestinal diseases |
US6083725A (en) * | 1996-09-13 | 2000-07-04 | Transkaryotic Therapies, Inc. | Tranfected human cells expressing human α-galactosidase A protein |
US6395884B1 (en) | 1996-09-13 | 2002-05-28 | Transkaryotic Therapies, Inc. | Therapy for α-galactosidase a deficiency |
US6566099B1 (en) | 1996-09-13 | 2003-05-20 | Transkaryotic Therapies, Inc. | Nucleic acid encoding a chimeric polypeptide |
US7122354B2 (en) | 1996-09-13 | 2006-10-17 | Transkaryotic Therapies, Inc. | Nucleic acid encoding a chimeric polypeptide |
US7833742B2 (en) | 2002-04-25 | 2010-11-16 | Shire Human Genetic Therapies, Inc. | Treatment of α-galactosidase A deficiency |
US9267166B2 (en) | 2002-04-25 | 2016-02-23 | Shire Human Genetic Therapies, Inc. | Treatment of α-galactosidase A deficiency |
US9523113B2 (en) | 2002-04-25 | 2016-12-20 | Shire Human Genetic Therapies, Inc. | Treatment of α-galactosidase A deficiency |
Also Published As
Publication number | Publication date |
---|---|
DK467188D0 (en) | 1988-08-19 |
ZA886517B (en) | 1989-05-30 |
FI884036A0 (en) | 1988-09-01 |
NO883883L (en) | 1989-03-02 |
NZ225983A (en) | 1990-09-26 |
NO883883D0 (en) | 1988-08-31 |
AU606453B2 (en) | 1991-02-07 |
JPH01165373A (en) | 1989-06-29 |
KR890005264A (en) | 1989-05-13 |
IL87622A0 (en) | 1989-01-31 |
PT88372A (en) | 1989-07-31 |
FR2619719A1 (en) | 1989-03-03 |
DK467188A (en) | 1989-03-02 |
EP0307285A1 (en) | 1989-03-15 |
PT88372B (en) | 1993-04-30 |
FR2619719B1 (en) | 1991-05-10 |
FI884036A (en) | 1989-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2411588A (en) | Improved process for the manufacture of 1,1,1- trifluorodichloroethane and 1,1,1,2-tetrafluorochloroethane | |
AU7469787A (en) | Process for the genetic modification of yeast | |
AU579812B2 (en) | Cell lines and their use for the production of proteins | |
AU587989B2 (en) | DMA fragments, expression vectors, proteins, hosts, and process for production of the proteins | |
AU2761388A (en) | Process for the production of ethers | |
AU589622B2 (en) | Process for the production of 2,2,6,6,-tetraalkyl 4 piperidylamines | |
AU3468689A (en) | Process for the preparation of dideoxycytidine | |
AU1560988A (en) | Process for the production of spherical particles | |
AU1616288A (en) | The manufacture of glassware articles of improved strength | |
AU2179688A (en) | Recombinant eukaryotic cells production interleukin-2, process and vectors for their preparation and process for the preparation of interleukin-2 | |
AU587648B2 (en) | Process for the preparation of (2,2)- paracyclophane | |
AU589196B2 (en) | Process for the production of 2,2,6,6-tetraalkyl-4- piperidylamines | |
AU590346B2 (en) | Process for the preparation of halogenated (2,2)- paracyclophanes and mixtures of resultant halogenated (2,2)-paracyclophanes | |
AU2346388A (en) | Improvements brought to solid catalysts in grain form, process for the preparation of these catalysts and applications for the latter | |
AU3066189A (en) | High yield protein production system | |
AU1969688A (en) | Manufacture of solar cells | |
AU1446988A (en) | Genetic engineering process for the preparation of polypeptides | |
AU2403988A (en) | Processed red blood cells and process for producing the same | |
AU2596888A (en) | Peptide structures, immunogens containing them and their uses in the control of fertility | |
AU8225187A (en) | Reduced-stability alpha-amylase and process for its production | |
AU2032788A (en) | Process for the preparation of naphthacenes | |
AU7522987A (en) | Process for the production of an explosive | |
AU2299588A (en) | Process for the production of polyethylene | |
NO178036C (en) | Process for Preparation of Fusion Proteins, Gene Structure, Vectors of Streptomycet Cells and the Fusion Proteins | |
AU1749888A (en) | Process for the production of 2-quinoxalines |